slide1 slide1 slide1
slide1 slide1 slide1
slide1 slide1 slide1
slide1 slide1 slide1

Lectures on SIMDAX

Use of levosimendan in Acute decompensated heart failure

Use of Levosimendan in Cardiac surgery

Use of Levosimendan in Advanced heart failure

Use of Levosimendan in Intensive and Critical Care

Read the biographies of the lecturers

 

Lectures at ESC 2018

 
Inotropes in Acute Heart Failure: from guidelines to practical use - Guidelines and patient characteristics, D. von Lewinski (AT), ESC 2018 Inodilators and renal function: how to avoid kidney dysfunction in Acute Heart Failure? - Cardio-renal syndrome, F. Fedele (IT), ESC 2018
   
Inodilators and renal function: how to avoid kidney dysfunction in Acute Heart Failure? - Cardio-renal syndrome, F. Gustafsson (DK), ESC 2018 Inotropes or inodilators in HFrEF: what to use, on whom, when and how? - What is available? G. Giannakoulas (GR), ESC 2018
   
Inotropes or inodilators in HFrEF: what to use, on whom, when and how? - Therapeutic options and clinical practice, R.H. Schwinger (DE), ESC 2018 Inotropes in Acute Heart Failure: from guidelines to practical use - Therapeutic options and clinical practice, F. Fruhwald (AT), ESC 2018
   
Acute Heart Failure related to acute coronary syndromes: is there a role for inodilators? Patient characteristics, V-P Harjola (FI), ESC 2018 Acute Heart Failure related to acute coronary syndromes: is there a role for inodilators? Therapeutic options, C. Tschöpe (DE), ESC 2018
   
Inodilators and renal function: how to avoid kidney dysfunction in Acute Heart Failure? - Therapeutic options and clinical practice, S. Matskeplishvili (RU), ESC 2018 Inotropes or inodilators in HFrEF: what to use, on whom, when and how? - What is available? Z. Papp (HU), ESC 2018
   
Inotropes or inodilators in HFrEF: what to use, on whom, when and how? - Therapeutic options and clinical practice, A. Borbély, (HU), ESC 2018 Inotropes in Acute Heart Failure: from guidelines to practical use - Therapeutic options and clinical practice, J. Parissis (GR), ESC 2018

   

Lectures at ESC Heart Failure 2018

 
Levosimendan in Acute Heart Failure: from guidelines to practical use - Patient characteristics, D. von Lewinski (AT), ESC-HF 2018 Levosimendan in Acute Heart Failure: from guidelines to practical use - Clinical practice and therapeutic options, G. Giannakoulas (GR), ESC-HF 2018
   
Levosimendan in HFrEF: on whom, when and how? - What is available? Z. Papp (HU), ESC-HF 2018 Levosimendan in HFrEF: on whom, when and how? - Therapeutic needs, V-P Harjola (FI), ESC-HF 2018
   
Levosimendan in HFrEF: on whom, when and how? - Clinical practice, J. Parissis (GR), ESC-HF 2018  
   
   

Lectures at ESC 2017

 

Inotropes in Acute Heart Failure - How to apply the guidelines in clincal practice? J. Parissis (GR), ESC 2017 Inotropes in Acute Heart Failure - From guidelines to practical use - Therapeutic needs vs available options, V-P Harjola (FI), ESC 2017
   
   
Inodilators and renal function - Proper treatment to avoid kidney dysfunction, S. Matskeplishvili (RU), ESC 2017 Inodilators and renal function - Cardio renal syndrome therapeutic options, F. Fedele (IT), ESC 2017
   
   
Inotropes or inodilators in HFrEF - Pros and cons of inodilators, in which patient? A. Mebazaa (FR), ESC 2017 Inotropes or inodilators in HFrEF what is available - Evidence and clinical practice, J. Masip (ES), ESC 2017
   
   
Inotropes in Acute Heart Failure - How to apply the guidelines in clinical practice? A.Mebazaa (FR), ESC 2017 Inotropes in Acute Heart Failure - From guidelines to practical use -  J. Masip (ES), ESC 2017
   
   
Inotropes and inodilators in HFrEF - Pros and cons - D. von Lewinski (AT), ESC 2017 Inotropes or inodilators in HFrEF - what to use, when and how? R.H.Schwinger (DE), ESC 2017
   
   

Lectures at ESC Heart Failure 2017

 
Inotropes or inodilators in HFrEF - what to use, on whom, when and how? What is available? Z. Papp (HU), ESC-HF 2017 Inotropes in Acute Heart Failure - from guidelines to practical use. The ESC Guidelines in practice, M. Kivikko (FI), ESC-HF 2017
   
Inotropes in Acute Heart Failure - from guidelines to practical use. Patients in need of inotropes, C. Tschöpe (DE), ESC-HF 2017 Inodilators and renal function - therapeutic options: what, when and why, J Parissis (GR), ESC-HF 2017
   
Inodilators and renal function - how to avoid kidney dysfunction in AHF - cardiorenal syndrome, D. Kindgen-Milles (DE), ESC-HF 2017 Inotropes and inodilators in HFrEF - what to use, on whom, when and how? The clinical practice, K. Karason (SE), ESC-HF 2017
   
Inotropes and inodilators in HFrEF - what to use, on whom, when and how? - The therapeutic needs, V-P Harjola (FI), ESC-HF 2017 Inodilators and renal function: How to avoid kidney dysfunction in AHF, F. Gustafsson (DK), ESC-HF 2017

Interested in seeing more? Go to lecture archives for videos from congresses in 2016 and beyond.

 

Read the biographies of the lecturers

 

Lectures at EACTA 2018

 
The LEVO-CTS and LICORN studies: co-analysis of the mortality results
in the isolated CABG patients, B. Cholley (FR), EACTA 2018
The LEVO-CTS and LICORN studies: evidence, recommendations, and
limitations for levosimendan, M. Heringlake (DE), EACTA 2018
   
The LEVO-CTS and LICORN studies in the light of the clinical practice, D. Bettex (CH), EACTA 2018  
 
   

Lectures at EACTA 2016

 
Levosimendan for optimising patient outcome in cardiac surgery, D. Bettex (CH), EACTA 2016 Effects of levosimendan on the renal function, S-E Ricksten (SE), EACTA 2016
   
Perioperative heart failure - still a challenge, M Siegemund (CH), EACTA 2016  
 
   

Lecture at ISICEM 2016

 
Levosimendan in cardiac surgery - a practical approach, S. Bouchez (BE), ISICEM 2016  
 

Interested in watching more videos on use of levosimendan in cardiac surgery? Go to lecture archives to see lectures from congresses 2015 and beyond.

 

Read the biographies of the lecturers

 

Lectures at ESC 2018

 
Repetitive use of inodilators in Advanced Heart Failure: Therapeutic options and clinical practice, Fabrizio Oliva (IT), ESC 2018 Repetitive use of inodilators in Advanced Heart Failure: Patient characteristics, Josep Comin-Colet (ES), ESC 2018
   
Repetitive use of inodilators in Advanced Heart Failure: Therapeutic options and clinical practice, Gerhard Pölzl (AT), ESC 2018  
 
   

Lectures at ESC Heart Failure 2018

 
Levosimendan and renal function: how to avoid kidney dysfunction in AHF? - Cardio-renal syndrome, Kristjan Karason (SE), ESC-HF 2018 Levosimendan and renal function: how to avoid kidney dysfunction in AHF? - Therapeutic options, Francesco Fedele (IT), ESC-HF 2018
   
Levosimendan and renal function: how to avoid kidney dysfunction in AHF? - Clinical practice, Finn Gustafsson (DK), ESC-HF 2018 Repetitive use of levosimendan in advanced heart failure - Scientific evidence in the literature, Carsten Tschöpe (GE), ESC-HF 2018
   
   
Repetitive use of levosimendan in advanced heart failure - Patient characteristics, Gerhard Pölzl (AU), ESC-HF 2018 Repetitive use of levosimendan in advanced heart failure - Clinical practice and new data, Fabrizio Oliva (IT), ESC-HF 2018
   
   

Lectures at ESC 2017

 
Repetitive use of inodilators in AdHF - The scientific evidence in literature, M. Kivikko (FI), ESC 2017 Repetitive use of inodilators in AdHF - The clinical practice, G. Giannakoulas (GR), ESC 2017
   
   
Inodilators and renal function - How to avoid kidney dysfunction in AdHF, M. Kivikko (FI), ESC 2017 Inodilators and renal function - proper treatment to avoid kidney dysfunction, G. Giannakoulas (GR), ESC 2017
   
   
Repetitive use of inodilators in AdHF - The scientific evidence in literature, J. Comin-Colet (ES), ESC 2017 Repetitive use of inodilators in AdHF - the clinical practice in AdHF, J. Delgado (ES), ESC 2017
   
   
Inotropes and clinical trials - how to select relevant endpoints, G. Pölzl (AT), ESC 2017 Inotropes and clinical trials - Hemodynamic and symptoms, QoL vs mortality, J. Altenberger (AT), ESC 2017
   
   

Lectures at ESC Heart Failure 2017

 
Repetitive use of Inodilators in Advanced Heart Failure - the scientific evidence, G. Pölzl (AT), ESC-HF 2017 Repetitive use of inodilators in Advanced Heart Failure - the rationale, J. Altenberger (AT), ESC-HF 2017

   
Repetitive use of Inodilators in Advance Heart Failure - the clinical practice, G. Malfatto (IT), ESC-HF 2017  
 
   

Interested in watching more videos on use of levosimendan in Advanced heart failure? Go to lecture archives for recordings of lectures from European clinical congresses from 2016 and beyond. 

 

Read the biographies of the lecturers

 

Lectures at ESICM LIVES 2018

 
The inodilator levosimendan in ICU, A. Herpain (BE), ESICM LIVES 2018 Need for hemodynamic support in ICU, B. Cholley (FR), ESICM LIVES 2018
   

Levosimendan for weaning from ECMO, A. Combes (FR), ESICM LIVES 2018

Levosimendan and Cardiogenic shock, F. Brünger (DE), ESICM LIVES 2018

   
Levosimendan and Septic shock, caveat, B. Levy (FR), ESICM LIVES 2018 Levosimendan and Septic shock, when yes, M. Girardis (IT), ESICM LIVES 2018
   
   
Levosimendan in pulmonary hypertension and right ventricular dysfunction, H. Riha (CZ), ESICM LIVES 2018 Levosimendan and renal function, M. Leone (FR), ESICM LIVES 2018
   
   

Lectures at ISICEM 2018

 
Renal effects of levosimendan, S-E Ricksten (SE), ISICEM 2018 Is the prolonged action of levosimendan of relevance with our patient LoS and pathologies? A. Herpain, ISICEM 2018
   
The hemodynamic effects of levosimendan: which patient will benefit from them? F. Guarracino,  ISICEM 2018 Perioperative effects of levosimendan in CABG, M. Heringlake (DE), ISICEM 2018
   
   
Efficacy and safety of levosimendan in the light of clinical practice, S. Bouchez, ISICEM 2018  
 
   

Lectures at ESICM LIVES 2017

 
Levosimendan in septic shock - epidemiology, T Liebgrets (DE), ESICM LIVES 2017  Effects of levosimendan on weaning - weaning from cardiac support, F. Sangalli, ESICM LIVES 2017
 
   
Levosimendan in septic shock - treatment modalities, F. Guarracino (IT), ESICM LIVES 2017 Levosimendan in septic shock - treatment modalitites, M.Girardis (IT), ESICM LIVES 2017
   
   
Effects of levosimendan on weaning - literature vs experience, A. Rudiger,  ESICM LIVES 2017 Levosimendan in septic shock - literature vs experience, A Herpain (BE), ESICM LIVES 2017
   
   
Levosimendan in cardiogenic shock - literature vs experience, B. Levy (FR), ESICM LIVES 2017 How to treat patients difficult to wean from ventilator, S. Bouchez (BE), ESICM LIVES 2017 
   
   
Effects of levosimendan on renal function, S-E Ricksten (SE), ESICM LIVES 2017  
 

 

Interested in seeing more videos on the use of levosimendan in intensive and critical care? Visit lecture archives to watch videos from congresses in 2016 and beyond.